Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 302Carboplatin 228Cisplatin 157Gemcitabine 155Paclitaxel 154Pemetrexed 122Bevacizumab 121Docetaxel 105Oxaliplatin 84durvalumab 82Nivolumab 81Fluorouracil 81Dexamethasone 79Cyclophosphamide 78atezolizumab 77130-nm albumin-bound paclitaxel 73Fulvestrant 71Capecitabine 69Injections 65Leucovorin 64Cetuximab 63Rituximab 56Lenalidomide 52fludarabine 51venetoclax 46Prednisone 45Irinotecan 44enzalutamide 41Letrozole 41tislelizumab 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Probenecid × 90 days × Clear all
NCT07160738 2026-04-03

A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060

Pfizer

Phase 1 Completed
25 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡